- Home
- / Evommune
Evommune
Revenue
$13 M
FY, 2025
Evommune Summary
Company Summary
- Overview
- Evommune is a biotechnology company that provides inflammatory disease treatment. It offers drug discovery and development, clinical research and therapeutic development, life-cycle management, and other services.
- Type
- Public
- Status
- Active
- Founded
- 2020
- HQ
- Palo Alto, CA, US | view all locations
- Website
- https://www.evommune.com
- Cybersecurity rating
Table of Contents
Key People
Eugene A. Bauer, Chief Medical Officer
Gregory S. Moss, Chief Corporate Strategy and Legal Officer
Jeegar Patel, Chief Scientific Officer
LocationsView all
1 location detected
Palo Alto, CA HQ
United States
1841 Page Mill Rd #100
Evommune Financials
Summary Financials
- Net income (Q1, 2026)
- ($21.7M)
- Cash (Q1, 2026)
- $48.3M
- EBIT (Q1, 2026)
- ($24.0M)